Baxter R C, Martin J L
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Proc Natl Acad Sci U S A. 1989 Sep;86(18):6898-902. doi: 10.1073/pnas.86.18.6898.
To determine the structure of the high molecular weight, growth hormone-dependent complex between the insulin-like growth factors (IGF-I and IGF-II) and their binding proteins in human serum, we have reconstituted the complex from its purified component proteins and analyzed it by gel electrophoresis and autoradiography after covalent cross-linking. The proteins tested in reconstitution mixtures were an acid-labile Mr 84,000-86,000 glycoprotein doublet (alpha subunit), an acid-stable Mr 47,000-53,000 glycoprotein doublet with IGF-binding activity (BP-53 or beta subunit), and IGF-I or IGF-II (gamma subunit). In incubations containing any one of the three subunits 125I-labeled and the other two unlabeled, identical 125I-labeled alpha-beta-gamma complexes of Mr 140,000 were formed. Minor bands of Mr 120,000 and 90,000 were also seen, thought to represent a partially deglycosylated form of the alpha-beta-gamma complex, and an alpha-gamma complex arising as a cross-linking artifact. When serum samples from subjects of various growth hormone status were affinity-labeled with IGF-II tracer, a growth hormone-dependent Mr 140,000 band was seen, corresponding to the reconstituted alpha-beta-gamma complex. Other growth hormone-dependent labeled bands, of Mr 90,000 (corresponding to alpha-gamma), Mr 55,000-60,000 (corresponding to labeled beta-subunit doublet), and smaller bands of Mr 38,000, 28,000, and 23,000-25,000 (corresponding to labeled beta-subunit degradation products), were also seen in the affinity-labeled serum samples and in the complex reconstituted from pure proteins. All were immunoprecipitable with an anti-BP-53 antiserum. We conclude that the growth hormone-dependent Mr 140,000 IGF-binding protein complex in human serum has three components: the alpha (acid-labile) subunit, the beta (binding) subunit, and the gamma (growth factor) subunit.
为确定人血清中胰岛素样生长因子(IGF-I和IGF-II)与其结合蛋白之间高分子量、生长激素依赖性复合物的结构,我们从其纯化的组成蛋白中重构了该复合物,并在共价交联后通过凝胶电泳和放射自显影进行分析。重构混合物中测试的蛋白包括一种酸不稳定的分子量为84,000 - 86,000的糖蛋白双峰(α亚基)、一种具有IGF结合活性的酸稳定的分子量为47,000 - 53,000的糖蛋白双峰(BP - 53或β亚基)以及IGF-I或IGF-II(γ亚基)。在含有三种亚基中任何一种用125I标记而另外两种未标记的孵育体系中,形成了分子量为140,000的相同的125I标记的α-β-γ复合物。还可见到分子量为120,000和90,000的次要条带,认为分别代表α-β-γ复合物的部分去糖基化形式以及作为交联假象产生的α-γ复合物。当用IGF-II示踪剂对不同生长激素状态受试者的血清样本进行亲和标记时,可见到一条生长激素依赖性的分子量为140,000的条带,对应于重构的α-β-γ复合物。在亲和标记的血清样本以及由纯蛋白重构的复合物中,还可见到其他生长激素依赖性标记条带,分子量为90,000(对应α-γ)、55,000 - 60,000(对应标记的β亚基双峰)以及分子量为38,000、28,000和23,000 - 25,000的较小条带(对应标记的β亚基降解产物)。所有这些条带都能用抗BP - 53抗血清进行免疫沉淀。我们得出结论,人血清中生长激素依赖性的分子量为140,000的IGF结合蛋白复合物有三个组分:α(酸不稳定)亚基、β(结合)亚基和γ(生长因子)亚基。